{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:26:07Z","timestamp":1789662367032,"version":"4.0.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1097\/md.0000000000004328","type":"journal-article","created":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T07:39:08Z","timestamp":1475653148000},"page":"e4328","source":"Crossref","is-referenced-by-count":25,"title":["Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer"],"prefix":"10.1097","volume":"95","author":[{"given":"Shuijin","family":"Lian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-49-20210309","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nrclinonc.2009.236","article-title":"Advanced pancreatic carcinoma: current treatment and future challenges","volume":"7","author":"Stathis","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"R2-49-20210309","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"R3-49-20210309","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMra0901557","article-title":"Pancreatic cancer","volume":"362","author":"Hidalgo","year":"2010","journal-title":"N Engl J Med"},{"key":"R4-49-20210309","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/aje\/kwr267","article-title":"Survival in population-based pancreatic cancer patients: San Francisco Bay area, 1995-1999","volume":"174","author":"Gong","year":"2011","journal-title":"Am J Epidemiol"},{"key":"R5-49-20210309","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jamcollsurg.2011.10.008","article-title":"Long-term results of resection of adenocarcinoma of the body and tail of the pancreas using radical antegrade modular pancreatosplenectomy procedure","volume":"214","author":"Mitchem","year":"2012","journal-title":"J Am Coll Surg"},{"key":"R6-49-20210309","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/000313481007600514","article-title":"The natural history of resected pancreatic cancer without adjuvant chemotherapy","volume":"76","author":"Hernandez","year":"2010","journal-title":"Am Surg"},{"key":"R7-49-20210309","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","article-title":"Pancreatic cancer","volume":"378","author":"Vincent","year":"2011","journal-title":"Lancet"},{"key":"R8-49-20210309","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","article-title":"The chemokine superfamily revisited","volume":"36","author":"Zlotnik","year":"2012","journal-title":"Immunity"},{"key":"R9-49-20210309","first-page":"6390","article-title":"Characterization of autostimulatory and transforming growth factors from human melanoma cells","volume":"45","author":"Richmond","year":"1985","journal-title":"Cancer Res"},{"key":"R10-49-20210309","doi-asserted-by":"crossref","first-page":"11570","DOI":"10.1128\/JVI.76.22.11570-11583.2002","article-title":"Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma","volume":"76","author":"Lane","year":"2002","journal-title":"J Virol"},{"key":"R11-49-20210309","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1073\/pnas.84.20.7188","article-title":"Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells","volume":"84","author":"Anisowicz","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"R12-49-20210309","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1158\/0008-5472.CAN-05-2871","article-title":"A growth-related oncogene\/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer","volume":"66","author":"Wang","year":"2006","journal-title":"Cancer Res"},{"key":"R13-49-20210309","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1593\/neo.07815","article-title":"Endothelial cells enhance tumor cell invasion through a crosstalk mediated by CXC chemokine signaling","volume":"10","author":"Warner","year":"2008","journal-title":"Neoplasia"},{"key":"R14-49-20210309","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cytogfr.2011.09.002","article-title":"The expression and role of CXC chemokines in colorectal cancer","volume":"22","author":"Verbeke","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"R15-49-20210309","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1189\/jlb.72.1.9","article-title":"Role of CXCL1 in tumorigenesis of melanoma","volume":"72","author":"Dhawan","year":"2002","journal-title":"J Leukoc Biol"},{"key":"R16-49-20210309","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1186\/1471-2407-14-781","article-title":"Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-beta signaling proteins","volume":"14","author":"Zou","year":"2014","journal-title":"BMC Cancer"},{"key":"R17-49-20210309","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.prp.2013.08.013","article-title":"Chemokine (C-X-C motif) ligand 1 (CXCL1) protein expression is increased in high-grade prostate cancer","volume":"210","author":"Miyake","year":"2014","journal-title":"Pathol Res Pract"},{"key":"R18-49-20210309","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1093\/annonc\/mdq739","article-title":"Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer","volume":"22","author":"Cheng","year":"2011","journal-title":"Ann Oncol"},{"key":"R19-49-20210309","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12935-014-0086-8","article-title":"Overexpression of Chemokine (C-X-C) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma","volume":"14","author":"Cao","year":"2014","journal-title":"Cancer Cell Inter"},{"key":"R20-49-20210309","doi-asserted-by":"crossref","first-page":"16472","DOI":"10.1073\/pnas.0605752103","article-title":"The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis","volume":"103","author":"Yang","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"R21-49-20210309","first-page":"1479","article-title":"GROalpha promotes invasion of colorectal cancer cells","volume":"24","author":"Ogata","year":"2010","journal-title":"Oncol Rep"},{"key":"R22-49-20210309","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/1471-2407-13-322","article-title":"Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers","volume":"13","author":"Miyake","year":"2013","journal-title":"BMC Cancer"},{"key":"R23-49-20210309","doi-asserted-by":"crossref","first-page":"12398","DOI":"10.18632\/oncotarget.2643","article-title":"Prognostic value of LAMP3 and TP53 overexpression in benign and malignant gastrointestinal tissues","volume":"5","author":"Sun","year":"2014","journal-title":"Oncotarget"},{"key":"R24-49-20210309","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/jcp.2010.085142","article-title":"Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma","volume":"64","author":"Huang","year":"2011","journal-title":"J Clin Pathol"},{"key":"R25-49-20210309","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/MPA.0b013e31819f6376","article-title":"Follow-up study of K-ras mutations in the plasma of patients with pancreatic cancer: correlation with clinical features and carbohydrate antigen 19-9","volume":"38","author":"Dabritz","year":"2009","journal-title":"Pancreas"},{"key":"R26-49-20210309","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1677\/ERC-10-0107","article-title":"The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor","volume":"17","author":"Bolitho","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"R27-49-20210309","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.canlet.2015.01.033","article-title":"CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer","volume":"359","author":"Wei","year":"2015","journal-title":"Cancer Lett"},{"key":"R28-49-20210309","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1084\/jem.20052124","article-title":"CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer","volume":"203","author":"Wang","year":"2006","journal-title":"J Exp Med"},{"key":"R29-49-20210309","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1158\/0008-5472.CAN-05-2570","article-title":"Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis","volume":"66","author":"Caunt","year":"2006","journal-title":"Cancer Res"},{"key":"R30-49-20210309","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/jlb.62.5.554","article-title":"The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer","volume":"62","author":"Arenberg","year":"1997","journal-title":"J Leukoc Biol"},{"key":"R31-49-20210309","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cyto.2011.10.019","article-title":"Down-regulation of CXCL1 inhibits tumor growth in colorectal liver metastasis","volume":"57","author":"Bandapalli","year":"2012","journal-title":"Cytokine"},{"key":"R32-49-20210309","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.4049\/jimmunol.167.11.6503","article-title":"CXCR2 deficiency confers impaired neutrophil recruitment and increased susceptibility during Toxoplasma gondii infection","volume":"167","author":"Del Rio","year":"2001","journal-title":"J Immunol"},{"key":"R33-49-20210309","doi-asserted-by":"crossref","first-page":"16278","DOI":"10.1073\/pnas.0804017105","article-title":"Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment","volume":"105","author":"Weber","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"R34-49-20210309","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2353\/ajpath.2006.040748","article-title":"Up-regulated expression of the CXCR2 ligand KC\/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression","volume":"168","author":"Boisvert","year":"2006","journal-title":"Am J Pathol"},{"key":"R35-49-20210309","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1158\/1078-0432.CCR-04-1518","article-title":"Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer","volume":"11","author":"Murphy","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R36-49-20210309","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0002-9440(10)62490-X","article-title":"Differential expression of interleukin-8 and its receptors in the neuroendocrine and non-neuroendocrine compartments of prostate cancer","volume":"166","author":"Huang","year":"2005","journal-title":"Am J Pathol"},{"key":"R37-49-20210309","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/ijc.24383","article-title":"CXC-chemokine\/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer","volume":"125","author":"Matsuo","year":"2009","journal-title":"Int J Cancer"},{"key":"R38-49-20210309","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.3892\/ol.2015.3614","article-title":"CXCL1 expression is correlated with Snail expression and affects the prognosis of patients with gastric cancer","volume":"10","author":"Xiang","year":"2015","journal-title":"Oncol Lett"},{"key":"R40-49-20210309","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1158\/1535-7163.MCT-14-0448","article-title":"miR141-CXCL1-CXCR2 signaling-induced Treg recruitment regulates metastases and survival of non-small cell lung cancer","volume":"13","author":"Lv","year":"2014","journal-title":"Mol Cancer Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000004328","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T06:10:04Z","timestamp":1692511804000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201607260-00049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":39,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000004328","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}